JP2010526884A5 - - Google Patents

Download PDF

Info

Publication number
JP2010526884A5
JP2010526884A5 JP2010517230A JP2010517230A JP2010526884A5 JP 2010526884 A5 JP2010526884 A5 JP 2010526884A5 JP 2010517230 A JP2010517230 A JP 2010517230A JP 2010517230 A JP2010517230 A JP 2010517230A JP 2010526884 A5 JP2010526884 A5 JP 2010526884A5
Authority
JP
Japan
Prior art keywords
administered
ribose
medicament
dose
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010517230A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010526884A (ja
JP5396387B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/000845 external-priority patent/WO2008091618A1/en
Publication of JP2010526884A publication Critical patent/JP2010526884A/ja
Publication of JP2010526884A5 publication Critical patent/JP2010526884A5/ja
Application granted granted Critical
Publication of JP5396387B2 publication Critical patent/JP5396387B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010517230A 2007-01-23 2008-01-23 心臓不整脈を治療するためのｄ−リボースの用途 Active JP5396387B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88194007P 2007-01-23 2007-01-23
US60/881,940 2007-01-23
PCT/US2008/000845 WO2008091618A1 (en) 2007-01-23 2008-01-23 Use of d-ribose to treat cardiac arrhythmias

Publications (3)

Publication Number Publication Date
JP2010526884A JP2010526884A (ja) 2010-08-05
JP2010526884A5 true JP2010526884A5 (OSRAM) 2011-03-17
JP5396387B2 JP5396387B2 (ja) 2014-01-22

Family

ID=39264528

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010517230A Active JP5396387B2 (ja) 2007-01-23 2008-01-23 心臓不整脈を治療するためのｄ−リボースの用途

Country Status (10)

Country Link
US (1) US8101581B2 (OSRAM)
EP (1) EP2120968B1 (OSRAM)
JP (1) JP5396387B2 (OSRAM)
CN (1) CN101588807B (OSRAM)
AT (1) ATE487485T1 (OSRAM)
BR (1) BRPI0806231A2 (OSRAM)
CA (1) CA2674717C (OSRAM)
DE (1) DE602008003411D1 (OSRAM)
ES (1) ES2352154T3 (OSRAM)
WO (1) WO2008091618A1 (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020119933A1 (en) * 2000-07-28 2002-08-29 Butler Terri L. Compositions and methods for improving cardiovascular function
US8101581B2 (en) 2007-01-23 2012-01-24 Bioenergy, Inc. Use of D-ribose to treat cardiac arrhythmias
WO2009123742A1 (en) * 2008-04-02 2009-10-08 St Cyr John A Use of ribose in first response to acute myocardial infarction
JP7082258B2 (ja) 2016-02-01 2022-06-08 バイオエナジー ライフ サイエンス，インコーポレイティド うっ血性心不全に罹っている対象を治療するためのリボースの使用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4719201A (en) 1985-02-07 1988-01-12 Regents Of The University Of Minnesota Method for stimulating recovery from ischemia
US4605644A (en) 1985-02-07 1986-08-12 Regents Of The University Of Minnesota Method for stimulating recovery from ischemia employing ribose and adenine
US4824660A (en) 1985-06-06 1989-04-25 Paul S. Angello Method of determining the viability of tissue in an organism
DE4228215A1 (de) * 1992-08-25 1994-03-03 Pliml Wolfgang Verwendung von Ribose zur Herstellung eines Arzneimittels zur Behandlung von Leistungsschwächen des Körpers, insbesondere von Organinsuffizienzen
RU2127548C1 (ru) * 1996-06-26 1999-03-20 Алабовский Владимир Владимирович Способ коронарографии в эксперименте
DE19650754A1 (de) * 1996-12-06 1998-06-10 Wolfgang Dr Pliml Ribose und Schlaganfall
US6218366B1 (en) 1998-06-19 2001-04-17 Bioenergy, Inc. Method for raising the hypoxic threshold
US6159942A (en) 1998-06-19 2000-12-12 Bioenergy, Inc. Compositions for increasing energy in vivo
US20020119933A1 (en) 2000-07-28 2002-08-29 Butler Terri L. Compositions and methods for improving cardiovascular function
US6429198B1 (en) 1999-04-12 2002-08-06 Bioenergy Inc. Compositions for increasing athletic performance in mammals
US6534480B2 (en) 1999-06-17 2003-03-18 Bioenergy Inc. Compositions for increasing energy in vivo
US6339716B1 (en) 1999-09-24 2002-01-15 Bioenergy Inc. Method for determining viability of a myocardial segment
US6159943A (en) 1999-09-24 2000-12-12 Bioenergy, Inc. Use of ribose to prevent cramping and soreness in muscles
US6511964B2 (en) 1999-09-24 2003-01-28 Bioenergy, Inc. Method for treating acute mountain sickness
US6703370B1 (en) 1999-10-27 2004-03-09 Bioenergy, Inc. Use of ribose to treat fibromyalgia
WO2001045502A1 (en) 1999-12-21 2001-06-28 Bioenergy Inc. Compositions for the storage of platelets
US6663859B2 (en) 2000-01-07 2003-12-16 Bioenergy, Inc. Compositions for enhancing the immune response
US6525027B2 (en) 2000-01-20 2003-02-25 Bioenergy Inc. Use of ribose supplementation for increasing muscle mass and decreasing body fat in humans
US6420342B1 (en) 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
IT1317043B1 (it) * 2000-06-14 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare potenziante il metabolismo energeticomuscolare, comprendente una alcanoil l-carnitina e ribosio.
US20030212006A1 (en) 2002-05-13 2003-11-13 Seifert John G. Method for reducing free radical formation in healthy individuals undergoing hypoxic exercise and medical conditions with increased oxygen free radicals
US8486859B2 (en) 2002-05-15 2013-07-16 Bioenergy, Inc. Use of ribose to enhance plant growth
US7687468B2 (en) 2003-05-14 2010-03-30 Viacell, LLC. Rejuvenation of stored blood
US8759315B2 (en) 2003-05-14 2014-06-24 Viacell, Llc Methods for rejuvenating
US20040229205A1 (en) 2003-05-16 2004-11-18 Ericson Daniel G. Compositions for the storage of platelets
US20090197818A1 (en) 2004-01-14 2009-08-06 St Cyr John A Use Of Ribose for Recovery From Anaesthesia
US20050277598A1 (en) 2004-04-29 2005-12-15 Maccarter Dean J Method for improving ventilatory efficiency
US20100099630A1 (en) 2004-04-29 2010-04-22 Maccarter Dean J Method for improving ventilatory efficiency
PL1800675T4 (pl) * 2005-12-23 2012-02-29 Nutricia Nv Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka, mangan, i/lub molibden oraz nukleozydy/nukleotydy do leczenia otępienia
US8835396B2 (en) 2006-12-15 2014-09-16 Bioenergy, Inc. Method and compositions for improving pulmonary hypertension
US8101581B2 (en) 2007-01-23 2012-01-24 Bioenergy, Inc. Use of D-ribose to treat cardiac arrhythmias
US20090197819A1 (en) 2007-03-20 2009-08-06 Clarence Albert Johnson Compositions for improving and repairing skin
US20080312169A1 (en) 2007-03-20 2008-12-18 Clarence Albert Johnson Cosmetic use of D-ribose
US20090232750A1 (en) 2008-03-13 2009-09-17 St Cyr John A Compositions for indoor tanning
WO2009123742A1 (en) 2008-04-02 2009-10-08 St Cyr John A Use of ribose in first response to acute myocardial infarction
US20090286750A1 (en) 2008-05-16 2009-11-19 Kasubick Robert V Use of ribose in lessening the clinical symptoms of aberrant firing of neurons

Similar Documents

Publication Publication Date Title
JP2010522242A5 (OSRAM)
JP2016034978A5 (OSRAM)
JP2013525444A5 (OSRAM)
JP2012255026A5 (OSRAM)
JP2014530874A5 (OSRAM)
JP2009535352A5 (OSRAM)
CA2683786C (en) Use of tapentadol in the treatment of pain and with a reduced incidence of tapentadol-induced side-effects
JP2009513660A5 (OSRAM)
JP2010529118A5 (OSRAM)
JP2012501986A5 (OSRAM)
JP2014530220A5 (OSRAM)
JP2010525055A5 (OSRAM)
JP2019517542A5 (OSRAM)
JP2011528333A5 (OSRAM)
JP2011225596A5 (OSRAM)
JP2010536849A5 (OSRAM)
JP2013541583A5 (OSRAM)
CL2008000461A1 (es) Uso de aclidinio en el tratamiento o prevencion de una enfermedad o un estado respiratorio en un paciente por inhalacion, sin producir en dicho paciente efectos antimuscarinicos sistemicos.
JP2014518860A5 (OSRAM)
JP2016510326A5 (OSRAM)
JP2013518124A5 (OSRAM)
JP2007523135A5 (OSRAM)
JP2015516419A5 (OSRAM)
JP2015522603A5 (OSRAM)
JP2012508256A5 (OSRAM)